Results for tag: "Batten Disease Drug"

Batten Disease is a rare, inherited disorder of the nervous system that affects children. It is a type of endocrine and metabolic disorder, and is caused by a genetic mutation that leads to the buildup of lipids in the brain. Treatment for Batten Disease is limited, and there is currently no cure. However, there are a number of drugs available to help manage the symptoms of the disease. These drugs are typically used to reduce seizures, improve cognitive function, and slow the progression of the disease. The Batten Disease Drug market is a small but growing market, with a number of companies developing treatments for the disease. These companies are focused on developing drugs that can help manage the symptoms of the disease, as well as treatments that can slow its progression. Some of the companies in the market include BioMarin Pharmaceuticals, Ultragenyx Pharmaceuticals, and Sanofi Genzyme. Show Less Read more